Page last updated: 2024-11-04

1,4-bis(2-(3,5-dichloropyridyloxy))benzene and Acute Liver Injury, Drug-Induced

1,4-bis(2-(3,5-dichloropyridyloxy))benzene has been researched along with Acute Liver Injury, Drug-Induced in 2 studies

1,4-bis(2-(3,5-dichloropyridyloxy))benzene: potent phenobarbital-like inducer of microsomal monooxygenase activity; structure given in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beilke, LD1
Aleksunes, LM1
Holland, RD1
Besselsen, DG1
Beger, RD1
Klaassen, CD1
Cherrington, NJ1
Baskin-Bey, ES1
Huang, W1
Ishimura, N1
Isomoto, H1
Bronk, SF1
Braley, K1
Craig, RW1
Moore, DD1
Gores, GJ1

Other Studies

2 other studies available for 1,4-bis(2-(3,5-dichloropyridyloxy))benzene and Acute Liver Injury, Drug-Induced

ArticleYear
Constitutive androstane receptor-mediated changes in bile acid composition contributes to hepatoprotection from lithocholic acid-induced liver injury in mice.
    Drug metabolism and disposition: the biological fate of chemicals, 2009, Volume: 37, Issue:5

    Topics: Animals; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure

2009
Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins.
    Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:1

    Topics: Animals; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Chemical

2006